Medicine and Dentistry
Action Potential Duration
8%
Atrial Fibrillation
100%
Cell Migration
8%
Cell Signaling Pathway
8%
Chronic Atrial Fibrillation
8%
down Regulation
16%
Extracellular Matrix
8%
Fibroblast
41%
Fibroblast
41%
Fibrosis
41%
HL-1 Cell Line
8%
In Vitro
16%
L-Type Calcium Channel
50%
Membrane Protein
8%
Monoclonal Antibody
8%
Muscle Cell
29%
Neutralizing Antibody
8%
Protein Expression
8%
Pulmonary Fibrosis
8%
Pulmonary Hypertension
8%
Signaling Mechanism
8%
Supraventricular Tachycardia
8%
Tachyarrhythmia
8%
Transforming Growth Factor Beta
83%
Transforming Growth Factor Beta1
25%
Transgenic Mouse
16%
Upregulation
8%
Biochemistry, Genetics and Molecular Biology
Action Potential Duration
5%
Atrial Fibrillation
50%
Atrial Fibrillation
50%
Atrial Tachycardia
5%
Calcium Channel Expression
11%
CD44
100%
Cell Migration
5%
CREB
100%
down Regulation
11%
Fibroblast
29%
Fibroblast
29%
L-Type Calcium Channel
35%
Membrane Protein
5%
Monoclonal Antibody
5%
Neutralizing Antibody
5%
Nomenclature
5%
Protein Expression
5%
Signaling Mechanism
5%
Supraventricular Tachycardia
5%
Tachyarrhythmia
5%
Tachycardia
5%
TGF Beta 1
17%
TGFBI
5%
Transforming Growth Factor Beta
52%
Transgenic Mouse
11%
Upregulation
5%
Immunology and Microbiology
Action Potential Duration
5%
Calcium Channel Expression
11%
Calcium Channel L Type
23%
CD44
100%
Cell Migration
5%
down Regulation
11%
Extracellular Matrix
5%
Fibroblast
29%
Fibroblast
29%
HL-1 Cell Line
5%
Immunology
5%
Monoclonal Antibody
5%
Muscle Cell
41%
Neutralizing Antibody
5%
Nomenclature
5%
Protein Expression
5%
Signaling Mechanism
5%
Transforming Growth Factor Beta
58%
Transforming Growth Factor Beta1
17%
Transgenic Mouse
11%
Upregulation
5%